176 related articles for article (PubMed ID: 19644069)
1. Granulocyte-colony stimulating factor delays PWI/DWI mismatch evolution and reduces final infarct volume in permanent-suture and embolic focal cerebral ischemia models in the rat.
Bråtane BT; Bouley J; Schneider A; Bastan B; Henninger N; Fisher M
Stroke; 2009 Sep; 40(9):3102-6. PubMed ID: 19644069
[TBL] [Abstract][Full Text] [Related]
2. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia.
Schäbitz WR; Kollmar R; Schwaninger M; Juettler E; Bardutzky J; Schölzke MN; Sommer C; Schwab S
Stroke; 2003 Mar; 34(3):745-51. PubMed ID: 12624302
[TBL] [Abstract][Full Text] [Related]
4. Do acute diffusion- and perfusion-weighted MRI lesions identify final infarct volume in ischemic stroke?
Rivers CS; Wardlaw JM; Armitage PA; Bastin ME; Carpenter TK; Cvoro V; Hand PJ; Dennis MS
Stroke; 2006 Jan; 37(1):98-104. PubMed ID: 16322499
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of hematopoietic growth factor therapy in chronic ischemic stroke in rats.
Zhao LR; Berra HH; Duan WM; Singhal S; Mehta J; Apkarian AV; Kessler JA
Stroke; 2007 Oct; 38(10):2804-11. PubMed ID: 17761920
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte colony-stimulating factor enhances arteriogenesis and ameliorates cerebral damage in a mouse model of ischemic stroke.
Sugiyama Y; Yagita Y; Oyama N; Terasaki Y; Omura-Matsuoka E; Sasaki T; Kitagawa K
Stroke; 2011 Mar; 42(3):770-5. PubMed ID: 21257824
[TBL] [Abstract][Full Text] [Related]
7. Strategies to improve post-stroke behavioral recovery in aged subjects.
Buga AM; Bălşeanu A; Popa-Wagner A; Mogoantă L
Rom J Morphol Embryol; 2009; 50(4):559-82. PubMed ID: 19942950
[TBL] [Abstract][Full Text] [Related]
8. Different treatment settings of Granulocyte-Colony Stimulating Factor and their impact on T cell-specific immune response in experimental stroke.
Dietel B; Cicha I; Achenbach S; Kollmar R; Garlichs C; Tauchi M
Immunol Lett; 2014; 158(1-2):95-100. PubMed ID: 24333341
[TBL] [Abstract][Full Text] [Related]
9. Granulocyte colony-stimulating factor regulates JNK pathway to alleviate damage after cerebral ischemia reperfusion.
Li YG; Liu XL; Zheng CB
Chin Med J (Engl); 2013 Nov; 126(21):4088-92. PubMed ID: 24229679
[TBL] [Abstract][Full Text] [Related]
10. Anti-apoptotic effect of granulocyte-colony stimulating factor after focal cerebral ischemia in the rat.
Solaroglu I; Tsubokawa T; Cahill J; Zhang JH
Neuroscience; 2006 Dec; 143(4):965-74. PubMed ID: 17084035
[TBL] [Abstract][Full Text] [Related]
11. A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF).
Schäbitz WR; Krüger C; Pitzer C; Weber D; Laage R; Gassler N; Aronowski J; Mier W; Kirsch F; Dittgen T; Bach A; Sommer C; Schneider A
J Cereb Blood Flow Metab; 2008 Jan; 28(1):29-43. PubMed ID: 17457367
[TBL] [Abstract][Full Text] [Related]
12. Decreased focal inflammatory response by G-CSF may improve stroke outcome after transient middle cerebral artery occlusion in rats.
Sehara Y; Hayashi T; Deguchi K; Zhang H; Tsuchiya A; Yamashita T; Lukic V; Nagai M; Kamiya T; Abe K
J Neurosci Res; 2007 Aug; 85(10):2167-74. PubMed ID: 17497673
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of postischemic thrombolysis with or without neuroprotection in a focal embolic model of cerebral ischemia.
Yang Y; Li Q; Miyashita H; Howlett W; Siddiqui M; Shuaib A
J Neurosurg; 2000 May; 92(5):841-7. PubMed ID: 10794299
[TBL] [Abstract][Full Text] [Related]
14. Delayed neuroprotective effect of insulin-like growth factor-i after experimental transient focal cerebral ischemia monitored with mri.
Schäbitz WR; Hoffmann TT; Heiland S; Kollmar R; Bardutzky J; Sommer C; Schwab S
Stroke; 2001 May; 32(5):1226-33. PubMed ID: 11340238
[TBL] [Abstract][Full Text] [Related]
15. Effects of a selective CD11b/CD18 antagonist and recombinant human tissue plasminogen activator treatment alone and in combination in a rat embolic model of stroke.
Zhang L; Zhang ZG; Zhang RL; Lu M; Krams M; Chopp M
Stroke; 2003 Jul; 34(7):1790-5. PubMed ID: 12805500
[TBL] [Abstract][Full Text] [Related]
16. Characterizing the diffusion/perfusion mismatch in experimental focal cerebral ischemia.
Meng X; Fisher M; Shen Q; Sotak CH; Duong TQ
Ann Neurol; 2004 Feb; 55(2):207-12. PubMed ID: 14755724
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of the efficacy of granulocyte-colony stimulating factor in animal models of focal cerebral ischemia.
Minnerup J; Heidrich J; Wellmann J; Rogalewski A; Schneider A; Schäbitz WR
Stroke; 2008 Jun; 39(6):1855-61. PubMed ID: 18403735
[TBL] [Abstract][Full Text] [Related]
18. Normobaric hyperoxia delays perfusion/diffusion mismatch evolution, reduces infarct volume, and differentially affects neuronal cell death pathways after suture middle cerebral artery occlusion in rats.
Henninger N; Bouley J; Nelligan JM; Sicard KM; Fisher M
J Cereb Blood Flow Metab; 2007 Sep; 27(9):1632-42. PubMed ID: 17311078
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effect of hyperbaric oxygen therapy monitored by MR-imaging after embolic stroke in rats.
Henninger N; Küppers-Tiedt L; Sicard KM; Günther A; Schneider D; Schwab S
Exp Neurol; 2006 Oct; 201(2):316-23. PubMed ID: 16814772
[TBL] [Abstract][Full Text] [Related]
20. Ischemic diffusion lesion reversal is uncommon and rarely alters perfusion-diffusion mismatch.
Chemmanam T; Campbell BC; Christensen S; Nagakane Y; Desmond PM; Bladin CF; Parsons MW; Levi CR; Barber PA; Donnan GA; Davis SM;
Neurology; 2010 Sep; 75(12):1040-7. PubMed ID: 20720188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
